Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.019 HKD | +5.56% |
|
+18.75% | +5.56% |
Valuation
Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Capitalization 1 | 295.7 | 120.7 | 93.18 | 93.99 | 768.8 | 37.97 |
Enterprise Value (EV) 1 | 276.7 | 230.6 | 300.1 | 284 | 937.7 | 135.7 |
P/E ratio | -10.6 x | -0.92 x | -1.45 x | -2.3 x | -18.3 x | -2 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.5 x | 0.27 x | 0.43 x | 0.58 x | 12.5 x | 2.36 x |
EV / Revenue | 0.47 x | 0.51 x | 1.4 x | 1.74 x | 15.3 x | 8.44 x |
EV / EBITDA | 7.82 x | -4.62 x | -202 x | 42.1 x | -42.6 x | -25.7 x |
EV / FCF | -52.8 x | 3.37 x | 8.55 x | 40.3 x | 157 x | 2.03 x |
FCF Yield | -1.9% | 29.7% | 11.7% | 2.48% | 0.64% | 49.3% |
Price to Book | 2.51 x | -9.42 x | -1.24 x | -0.78 x | -7.32 x | -0.33 x |
Nbr of stocks (in thousands) | 810,250 | 810,250 | 810,250 | 810,250 | 1,898,291 | 1,898,291 |
Reference price 2 | 0.3650 | 0.1490 | 0.1150 | 0.1160 | 0.4050 | 0.0200 |
Announcement Date | 27/06/19 | 29/06/20 | 22/07/21 | 12/08/22 | 30/06/23 | 28/06/24 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales 1 | 593 | 452.1 | 214.3 | 162.8 | 61.36 | 16.09 |
EBITDA 1 | 35.39 | -49.88 | -1.482 | 6.752 | -21.99 | -5.276 |
EBIT 1 | -9.984 | -91.1 | -16.69 | -1.15 | -25.16 | -5.362 |
Operating Margin | -1.68% | -20.15% | -7.79% | -0.71% | -41% | -33.33% |
Earnings before Tax (EBT) 1 | -22.1 | -132.2 | -58.45 | -46.45 | -34.46 | -19.32 |
Net income 1 | -27.92 | -130.9 | -64.43 | -40.85 | -28.88 | -19.56 |
Net margin | -4.71% | -28.94% | -30.06% | -25.09% | -47.07% | -121.58% |
EPS 2 | -0.0345 | -0.1615 | -0.0795 | -0.0504 | -0.0221 | -0.0100 |
Free Cash Flow 1 | -5.246 | 68.41 | 35.09 | 7.05 | 5.978 | 66.9 |
FCF margin | -0.88% | 15.13% | 16.37% | 4.33% | 9.74% | 415.9% |
FCF Conversion (EBITDA) | - | - | - | 104.42% | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 27/06/19 | 29/06/20 | 22/07/21 | 12/08/22 | 30/06/23 | 28/06/24 |
Balance Sheet Analysis
Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 110 | 207 | 190 | 169 | 97.8 |
Net Cash position 1 | 19 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | -2.202 x | -139.6 x | 28.15 x | -7.682 x | -18.53 x |
Free Cash Flow 1 | -5.25 | 68.4 | 35.1 | 7.05 | 5.98 | 66.9 |
ROE (net income / shareholders' equity) | -21.2% | -229% | 219% | 54.2% | 31% | 17.9% |
ROA (Net income/ Total Assets) | -2.93% | -28.8% | -4.64% | -0.36% | -10.8% | -2.56% |
Assets 1 | 953 | 454.8 | 1,389 | 11,423 | 266.4 | 763.1 |
Book Value Per Share 2 | 0.1500 | -0.0200 | -0.0900 | -0.1500 | -0.0600 | -0.0600 |
Cash Flow per Share 2 | 0.0400 | 0.0300 | 0.0200 | 0 | 0 | 0 |
Capex 1 | 33.3 | 4.65 | 7.72 | 1.91 | - | - |
Capex / Sales | 5.61% | 1.03% | 3.6% | 1.17% | - | - |
Announcement Date | 27/06/19 | 29/06/20 | 22/07/21 | 12/08/22 | 30/06/23 | 28/06/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-18.91% | 88.18B | |
+0.65% | 46.43B | |
-7.90% | 18.06B | |
+115.80% | 10.58B | |
-3.44% | 10.02B | |
-16.77% | 5.68B | |
-0.32% | 4.45B | |
-10.10% | 4.34B | |
+6.53% | 3.56B |
- Stock Market
- Equities
- 8056 Stock
- 8056 Stock
- Financials LIFE CONC